The release of the 2025-2026 American Association of Colleges of Pharmacy (AACP) Argus Commission Forecast comes at an important time for pharmacy. Colleges and schools of pharmacy are navigating financial pressures, changing applicant trends, rapid advances in artificial intelligence, evolving educational models, and an expanding vision for pharmacists’ role in patient care. Rather than attempting to predict the future, the Argus Commission has done something more valuable. It has challenged the profession to think strategically about where pharmacy education is headed and how today’s decisions may shape tomorrow’s workforce.
Reading the report, I found myself agreeing with much of its analysis. It is balanced, thoughtful, and intentionally designed to stimulate discussion rather than provide definitive answers. The Commission deserves credit for asking difficult questions while encouraging pharmacy educators and leaders to prepare for a future that remains uncertain.
As I worked through each section, one question continued to surface. It was not a question about enrollment, accreditation, artificial intelligence (AI), or institutional finances. It was a question shaped by nearly 4 decades of pharmacy practice and more than 2 decades serving veterans: How will these strategic decisions ultimately be experienced by the patients who depend on us? That question deserves a place alongside every discussion about workforce planning.
The Forecast devotes considerable attention to the financial pressures facing pharmacy education. Survey respondents expressed differing opinions about whether significant numbers of pharmacy programs could close or merge over the next 5 years, illustrating the uncertainty facing higher education and the financial realities confronting many institutions.¹ Whether those scenarios ultimately occur is almost secondary to the broader conversation they encourage.
Every decision made in pharmacy education eventually reaches a patient. Sometimes that connection is obvious. More often, it develops gradually over many years. Decisions about enrollment, faculty investment, curriculum design, experiential education, and institutional sustainability influence where pharmacists are trained, the careers they pursue, and ultimately the communities they serve.
National workforce projections remain an essential part of that discussion. The US Bureau of Labor Statistics projects approximately 14,200 pharmacist openings annually, driven primarily by retirements and workforce turnover rather than rapid employment growth.² Encouragingly, pharmacy school applications have begun to rebound after several challenging admission cycles.³ These data answer an important question: Are we educating enough pharmacists?
Patients experience something much more tangible. They experience whether a pharmacist is available in their community when they need one. They experience whether an ambulatory care clinic can recruit a clinical pharmacist, whether comprehensive medication management remains available after a retirement, or whether specialized pharmacist services continue close to home. Supply and distribution are related, but they are not synonymous.
Across many rural communities, recruiting pharmacists into specialized clinical positions remains difficult. When vacancies occur, replacing those services may take months. During that time, patients can temporarily lose convenient access to anticoagulation management, chronic disease education, medication optimization, and other pharmacist-provided services that have become integral to modern health care.
